US FDA Compassionate Use Reviews ‘Not Affected’ By Trump Policies

 
• By Kate Rawson
  
OCE's Project Facilitate, which helps doctors navigate the expanded access process, could expand beyond oncology, Richard Pazdur said. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from United States